HIV-infected adults currently are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, will enroll approximately 240 men and women between the ages of 18 and 64.
No responses to "NIAID Trial of 2009 H1N1 Influenza Vaccine Enrolling HIV-Positive Adults"
Comments on this story? Leave a note below.
Comments are closed.